REVIEW PAPER
Effect of vitamin D level on COVID-19 and the risk of complications in children
1
Nursing Department, Institute of Health Sciences, Małopolska State University, captain W. Pilecki in Oświęcim, Polska
Submission date: 2022-08-04
Final revision date: 2022-10-21
Acceptance date: 2022-12-18
Publication date: 2023-06-14
Corresponding author
Anita Kocięba-Łaciak
Anita Kocięba-Łaciak, MD, PhD, Nursing Department, Institute of Health Sciences, Małopolska State University, captain W. Pilecki in Oświęcim, Polska
Anita Kocięba-Łaciak, MD, PhD, Nursing Department, Institute of Health Sciences, Małopolska State University, captain W. Pilecki in Oświęcim, Polska
Pediatr Pol 2023;98(2):140-144
KEYWORDS
TOPICS
ABSTRACT
The immunomodulatory and pro-apoptotic role of vitamin D is still being investigated and the relationship between its deficiency and the development of many diseases is widely described. Vitamin D deficiency, which is prevalent in the world population, is under investigation, especially in the current epidemiological situation and the risk of complications from COVID-19, including multisystem inflammatory syndrome in children. Recommendations regarding the norms of vitamin D levels in children suggest monitoring of its concentration in groups at risk of deficiency and supplementation to the optimal level. Studies on the relationship of vitamin D deficiency with the severity of COVID-19 and an increased risk of complications after the disease suggest strong associations. At the same time, the literature review also noted data that indicated no or only a small effect of vitamin D on the morbidity of the studied population.
REFERENCES (54)
1.
Nair R, Maseeh A. Vitamin D: the “sunshine” vitamin. J Pharmacol Pharmacother 2012; 3: 118-126.
2.
Sizar O, Khare S, Goyal A, et al. Vitamin D deficiency. StatPearls Publishing, Treasure Island 2022.
3.
Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017; 18: 153-165.
4.
Płudowski P, Ducki C, Konstantynowicz J, et al. Vitamin D status in Poland. Pol Arch Med Wewn 2016; 126: 530-539.
5.
Rusińska A, Płudowski P, Walczak M, et al. Zasady suplementacji i leczenia witaminą D – nowelizacja 2018 r. Stand Med Ped 2018; 15: 531-559.
6.
Krasińska A, Skowrońska B. Znaczenie witaminy D u pacjentów z nadmierną masą ciała – nowe zasady suplementacji. Forum Zab Metab 2014; 5: 63-70.
7.
Napiórkowska L, Franek E. Rola oznaczania witaminy D w praktyce klinicznej. Chor Serca Naczyń 2009; 6: 203-210.
8.
Biesalski HK. Vitamin D deficiency and co-morbidities in COVID-19 patients – a fatal relationship? Nfs J 2020; 20: 10-21.
9.
Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134: 1129-1140.
10.
Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and Covid- 19 infections and deaths. Nutrients 2020; 12: 1-37.
11.
Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutrition 2003; 89: 552-572.
12.
Holick MF. The vitamin D epidemic and its health consequences. J Nutrition 2005; 135: 2739-2748.
13.
Turer CB, Lin H, Flores G. Prevalence of vitamin D deficiency among overweight and obese US children. Pediatrics 2013; 131: e152-e161.
14.
Desprez PY, Poujol D, Falette N, et al. 1,25-dihydroxyvitamin D3 increases epidermal growth factor receptor gene expression in BT-20 breast carcinoma cells. Biochem Biophys Res Commun 1991; 176: 1-6.
15.
Bouillon R, Eelen G, Verlinden L, et al. Vitamin D and cancer. J Steroid Biochem Mol Biol 2006; 102: 156-162.
16.
Kuryłowicz A, Bednarczuk T, Nauman J. Wpływ niedoboru witaminy D na rozwój nowotworów i chorób autoimmunologicznych. Endokrynol Pol 2007; 58: 140-152.
17.
Herr C, Greulich T, Koczulla R, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res 2011; 12: 31. . .
18.
Taylor S, Lopez P, Weckx L, et al. Respiratory viruses and influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. J Infect 2017; 74: 29-41.
19.
Feketea G, Vlacha V, Pop RM, et al. Relationship between vitamin D level and platelet parameters in children with viral respiratory infections. Front Pediatr 2022; 7: 1-8.
20.
Curwen M. Excess winter mortality in England and Wales with special reference to the effects of temperature and influenza. In: Charlton J, Murphy M, eds. The Health of Adult Britain 1841–1994. The Stationery Office, London 1997, 205-216.
21.
Jolliffe DA, Camargo CA, Sluyter JD, at al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol 2021; 9: 276-292.
22.
Flynn L, Zimmerman LH, McNorton K, et al. Effects of vitamin D deficiency in critically ill surgical patients. Am J Surg 2012; 203: 379-382.
23.
Yılmaz H, Sahiner E, Darcin T, et al. Is vitamin D supplementation a new hope for the therapy of the septic shock? Endocr Regul 2013; 47: 133-136.
24.
De Haan K, Groeneveld AB, De Geus HR, et al. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis. Crit Care 2014; 18: 660.
25.
Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017; 15: i6583.
26.
Wang Y, Yang Z, Gao L, et al. Effects of a single dose of vitamin D in septic children: a randomized, double-blinded, controlled trial. J Int Med Res 2020; 48: 1-11.
27.
Madden K, Feldman HA, Smith EM, et al. Vitamin D deficiency in critically ill children. Pediatrics 2012; 130: 421-428.
28.
McNally JD, Nama N, O’Hearn K, et al. Vitamin D deficiency in critically ill children: a systematic review and meta-analysis. Crit Care 2017; 21: 287.
29.
Paiva C, Bettinelli L, Pasqualotti A, et al. Prevalence of hypovitaminosis D in institutionalized elderly. O Mundo Da Saude 2017; 41: 40-47.
30.
Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res 2020; 32: 1195-1198.
31.
Jakovac H. COVID-19 and vitamin D-is there a link and an opportunity for intervention? Am J Physiol Endocrinol Metab 2020; 318: E589.
32.
Panarese A, Shahini E. COVID-19, and vitamin D. Aliment Pharmacol Ther 2020; 51: 993-995.
33.
Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020; 145: e20200702.
34.
Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020; 109: 1088-1095.
35.
Chow EJ, Englund JA. Severe acute respiratory syndrome coronavirus 2 infections in children. Infect Dis Clin North Am 2022; 36: 435-479.
36.
Leidman E, Duca LM, Omura JD, et al. COVID-19 trends among persons aged 0–24 years – United States, March 1 – December 12, 2020. Morb Mortal Wkly Rep 2021; 70: 88-94.
37.
Wei M, Yuan J, Liu Y, et al. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA 2020; 323: 1313-1314.
38.
Adeyinka A, Bailey K, Pierre L, et al. COVID 19 infection: pediatric perspectives. J Am Coll Emerg Physicians Open. 2021; 2: e12375:.
39.
Tosif S, Neeland MR, Sutton P, et al. Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19. Nat Commun 2020; 11: 5703.
40.
Torres Acosta MA, Singer BD. Pathogenesis of COVID-19-induced ARDS: implications for an aging population. Eur Respir J 2020; 56: 1-27.
41.
Dancer RCA, Parekh D, Lax S, et al. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax 2015; 70: 617-624.
42.
Bajwa EK, Bhan I, Quraishi S, et al. Low vitamin D status occurs in 90% of patients with ARDS and is associated with longer duration of mechanical ventilation. Am J Respir Crit Care Med 2016; 193: A1846.
43.
Pereira M, Damascena AD, Azevedo LMG, et al. Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr 2022; 62: 1308-1316.
44.
Sun X, Wang T, Cai D, et al. Cytokine storm intervention in the early stages of COVID-19 pneumonia. Cytokine Growth Factor Rev 2020; 53: 38- 42. .
45.
Bergman P. Can vitamin D protect against covid-19? Two new trials find no effect, but aren’t the final word. BMJ 2022; 378: o1822.
46.
Ramcharan T, Nolan O, Lai CY, et al. Paediatric inflammatory multisystem syndrome: temporally associated with SARSCoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr Cardiol 2020; 41: 1391-1401.
47.
Kaushik S, Aydin SI, Derespina KR, et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection: a multi-institutional study from New York City. J Pediatr 2020; 224: 24-29.
48.
Shekerdemian LS, Mahmood NR, Wolfe KK, et al. International COVID-19 PICU collaborative. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr 2020; 174: 868-873.
49.
Chao JY, Derespina KR, Herold BC, et al. Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 at a tertiary care medical Center in New York City. J Pediatr 2020; 223: 14-19.
50.
Capone CA, Subramony A, Sweberg T, et al. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory disease of childhood (MIS-C) associated with SARS-CoV-2 infection. J Pediatr 2020; 224: 141-145.
51.
Rivera DT, Misra A, Sanil Y, et al. Vitamin D and morbidity in children with Multisystem inflammatory syndrome related to COVID-19. Prog Pediatr Cardiol 2022; 101507: 1-15.
52.
Nakra NA, Blumberg DA, Herrera-Guerra A, et al. Multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel) 2020; 7: 69.
53.
Mitchell F. Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol 2020; 8: 570.
54.
Silberstein M. Vitamin D: a simpler alternative to tocilizumab for trial in COVID-19? Med Hypotheses 2020; 140: 109767.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
